Mitsubishi Chemical Group Corporation Transaction Overview Transfer of Mitsubishi Tanabe Pharma Corporation

Representative Corporate Executive Officer, President and Chief Executive Officer
Manabu Chikumoto
Vice President, Chief Financial Officer
Minoru Kida
Vice President, Supervising – Portfolio Transformation Promotion
Ken Araki

PLAY LIST

from the beginning

Transaction Overview Transfer of Mitsubishi Tanabe Pharma Corporation

Today's summary

Transaction overview

Strategic rationale of the transaction

Strategic direction after the transfer

Use of proceeds from the transfer

Capital allocation after the transfer

Financial impact from the transfer

(Reference) FY2029 target after the transfer (by Segment)

(Reference) Overview of Bain Capital

Q&A1

Q&A2

Q&A3

Q&A4

Q&A5

Q&A6

Q&A7

Back
Next

Download

Presentation File(PDF 498 KB)